Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-03-31, Stock:JNJ, The news for the past five days is as follows:
2020-03-24: nan
2020-03-25: NEWS1: Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus.NEWS2: The Top Health Care Companies in the World.NEWS3: J&J's Chief Scientific Officer predicts vaccinations against coronavirus within 12 months.NEWS4: 'We are making good progress with a vaccine' says JNJ Chief Scientific Officer on coronavirus.NEWS5: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS6: EU says Johnson & Johnson's deal for Takeda patch may harm competition.NEWS7: EU regulators to probe Johnson & Johnson's Takeda deal.NEWS8: Johnson & Johnson Weathers Storm but Needs to Build a New Base.
2020-03-26: NEWS1: Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus.
2020-03-27: NEWS1: Contractors can expect more funding, and flexibility, from coronavirus stimulus package.NEWS2: Is Abbott A Buy After Gaining FDA Blessing For Its Coronavirus Test?.
2020-03-30: NEWS1: US Indexes Close Higher Monday.NEWS2: Stock investors are too optimistic — they’re running up Abbott, Johnson & Johnson and General Motors without doing any research.NEWS3: Stay-at-Home Orders Expand; J&J in Vaccine Deal: Virus Update.NEWS4: The Dow Surged 691 Points Because Investors Have More Hope Covid-19 Will Be Beat.NEWS5: TREASURIES-Benchmark yield recovers in late trading.NEWS6: Johnson & Johnson to begin human trials on COVID-19 vaccine by Sept..NEWS7: Dow Gains 691 Points As Coronavirus Lockdown Extends Through April 30.NEWS8: US STOCKS-Wall Street rallies, led by healthcare jump.NEWS9: Covid Report: Gilead Nears Coronavirus Data In 'Weeks'; J&J Bullish On Vaccine.NEWS10: Dow books nearly 700-point gain as investors eye efforts to slow coronavirus spread.NEWS11: Johnson & Johnson Says Its Coronavirus Vaccine Could Be Ready Early Next Year.NEWS12: US Stock Market Overview &#8211; Stocks Rally, Led by Healthcare, Energy Bucks the Trend.NEWS13: Johnson & Johnson, Merck share gains lead Dow's nearly 725-point surge.NEWS14: Wall Street Gains on Monday.NEWS15: Johnson & Johnson, Merck share gains contribute to Dow's nearly 575-point surge.NEWS16: US STOCKS-Wall St gains as U.S. extends shutdown to limit virus spread.NEWS17: Afternoon Market Stats in 5 Minutes.NEWS18: Ready to buy back into this market? If so, forget about Apple and grab these stocks instead, strategist says.NEWS19: Coronavirus update: 755,591 cases world-wide, 36,211 deaths; Italy, Spain and New York City struggle to cope.NEWS20: Dow soars 438 points on gains for Microsoft, Johnson & Johnson shares.NEWS21: When Will a Coronavirus Vaccine be Ready? These 9 Programs Are Making Progress..NEWS22: Dow gains more than 500 points as market focuses on efforts to slow coronavirus spread.NEWS23: Johnson & Johnson, Microsoft share gains lead Dow's 525-point surge.NEWS24: Johnson & Johnson, Merck share gains contribute to Dow's 490-point surge.NEWS25: US STOCKS- Wall St gains as U.S. extends shutdown to limit virus spread.NEWS26: Coronavirus update: 741,030 cases world-wide, 35,114 deaths; Italy, Spain and New York City struggle to cope.NEWS27: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS28: Dow Jones Climbs 500 Points, As Stock Market Correction Continues; U.S. Coronavirus Cases Top 145,000.NEWS29: Johnson & Johnson, Intel share gains lead Dow's 425-point rally.NEWS30: Does Johnson & Johnson's Potential Coronavirus Vaccine Make It a Buy?.NEWS31: Johnson & Johnson Identifies Lead Coronavirus Vaccine Candidate.NEWS32: Dow's 325-point rally highlighted by gains in shares of Johnson & Johnson, Intel.NEWS33: Dow Jones Climbs 300 Points, As Stock Market Correction Continues; U.S. Coronavirus Cases Top 144,000.NEWS34: US STOCKS-Wall St gains as investors weigh stimulus against shutdown.NEWS35: Dow under pressure as Boeing sinks, but broader stocks gain as market focuses on efforts to slow coronavirus spread.NEWS36: Johnson & Johnson Is Ready to Rally After Reaching a Downside Price Target.NEWS37: COVID-19 Vaccine Updates: J&J Identifies Lead Candidate, IMV Eyes Clinical Testing In Summer, Altimmune Partners With University Of Alabama.NEWS38: Johnson & Johnson Gets Boost After Announcing September Trials Of Vaccine Planned.NEWS39: Dow Jones Today, Climb On Coronavirus News, Spending; Johnson & Johnson, Abbott Labs Jump.NEWS40: Stocks - Abbott, J&J Rise in Premarket on Covid-19 Treatment Hopes.NEWS41: Johnson & Johnson Says It Will Begin Manufacturing a Coronavirus Vaccine Immediately.NEWS42: Johnson & Johnson identifies a lead COVID-19 vaccine candidate.NEWS43: US STOCKS-Wall St set to open higher as investors weigh stimulus against shutdown.NEWS44: Dow Jones Today, Futures Rise As Coronavirus News Drives Premarket; Johnson & Johnson, Abbott Labs Jump.NEWS45: J&J, U.S. government plan 1 billion doses of coronavirus vaccine.NEWS46: Benzinga Pro's Stock To Watch For Mon., Mar. 30, 2020: Johnson & Johnson (JNJ).NEWS47: J&J, U.S. government plan one billion doses of coronavirus vaccine.NEWS48: J&J has a COVID-19 vaccine candidate, Phase 1 trials to start in September.NEWS49: Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use.

Answer: Decrease